Posters
Presentation Type
Poster
Discipline Track
Clinical Science
Abstract Type
Program Abstract
Abstract
Background: The advancement of biomedicine demands tools that translate its achievements into services to both the scientific community and the pharma/biotech industry. Biobanks are powerful tools that collect, process, store, manage, and distribute biospecimens and their associated clinical/demographic data to users carrying out studies aimed at causing a real public health impact.
For our laboratory to offer pharma/biotech companies support for their projects with the highest quality possible biospecimens we adopted the Best Biobanking Practices from ISBER (https://www.isber.org/).
Methods: As a result of the pandemics, great effort has been dedicated to help the health ecosystem through a diagnostic service for SARS CoV-2 (by RT-PCR). Emphasis was put on proper sample collection, preanalytical characterization, and storage in ultra-low freezers. Their pre-analytical characterization included determining yield and purity by spectrophotometry using the NanoDropTM 2000 (Thermo-Fisher. Mexico City, Mexico).
Results: We biobanked and supplied to internal (our Genetics laboratory) and external (validation protocols of pharma/biotech international companies) clients almost 2,000 RNA samples. Given the preanalytical qualification of the biospecimens, they performed satisfactorily for our clients’ diagnostic and innovation protocols needs.
Conclusions: The biobanking services provided to both our diagnostic laboratory and to pharma/biotech companies that contracted our services delivered research materials of the highest quality. Being a private biobank recognized now nationally and internationally by public and private institutions has allowed us to participate in projects evaluating innovative diagnostics methods and devices.
Academic/Professional Position
Faculty
Recommended Citation
Rodríguez-Palacios, Raúl; Walle-Gloria, Nathalia L.; and Barrera-Saldaña, Hugo A., "Biobanking in NE Mexico for biomedical research and clinical needs" (2023). Research Symposium. 27.
https://scholarworks.utrgv.edu/somrs/theme1/posters/27
Included in
Biobanking in NE Mexico for biomedical research and clinical needs
Background: The advancement of biomedicine demands tools that translate its achievements into services to both the scientific community and the pharma/biotech industry. Biobanks are powerful tools that collect, process, store, manage, and distribute biospecimens and their associated clinical/demographic data to users carrying out studies aimed at causing a real public health impact.
For our laboratory to offer pharma/biotech companies support for their projects with the highest quality possible biospecimens we adopted the Best Biobanking Practices from ISBER (https://www.isber.org/).
Methods: As a result of the pandemics, great effort has been dedicated to help the health ecosystem through a diagnostic service for SARS CoV-2 (by RT-PCR). Emphasis was put on proper sample collection, preanalytical characterization, and storage in ultra-low freezers. Their pre-analytical characterization included determining yield and purity by spectrophotometry using the NanoDropTM 2000 (Thermo-Fisher. Mexico City, Mexico).
Results: We biobanked and supplied to internal (our Genetics laboratory) and external (validation protocols of pharma/biotech international companies) clients almost 2,000 RNA samples. Given the preanalytical qualification of the biospecimens, they performed satisfactorily for our clients’ diagnostic and innovation protocols needs.
Conclusions: The biobanking services provided to both our diagnostic laboratory and to pharma/biotech companies that contracted our services delivered research materials of the highest quality. Being a private biobank recognized now nationally and internationally by public and private institutions has allowed us to participate in projects evaluating innovative diagnostics methods and devices.